Fused Tetrahydroquinolines Are Interfering with Your Assay.
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
09 11 2023
09 11 2023
Historique:
medline:
10
11
2023
pubmed:
24
10
2023
entrez:
24
10
2023
Statut:
ppublish
Résumé
Tricyclic tetrahydroquinolines (THQs) have been repeatedly reported as hits across a diverse range of high-throughput screening (HTS) campaigns. The activities of these compounds, however, are likely due to reactive byproducts that interfere with the assay. As a lesser studied class of pan-assay interference compounds, the mechanism by which fused THQs react with protein targets remains largely unknown. During HTS follow-up, we characterized the behavior and stability of several fused tricyclic THQs. We synthesized key analogues to pinpoint the cyclopentene ring double bond as a source of reactivity of fused THQs. We found that these compounds degrade in solution under standard laboratory conditions in days. Importantly, these observations make it likely that fused THQs, which are ubiquitously found within small molecule screening libraries, are unlikely the intact parent compounds. We urge deprioritization of tricylic THQ hits in HTS follow-up and caution against the investment of resources to follow-up on these problematic compounds.
Identifiants
pubmed: 37874947
doi: 10.1021/acs.jmedchem.3c01277
pmc: PMC10641811
doi:
Substances chimiques
1,2,3,4-tetrahydroquinoline
CCR50N1Z9G
Small Molecule Libraries
0
Quinolines
0
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14434-14446Références
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Eur J Pharm Sci. 2017 May 30;103:60-69
pubmed: 28185990
Eur J Med Chem. 2020 Apr 15;192:112156
pubmed: 32114360
Assay Drug Dev Technol. 2007 Jun;5(3):319-32
pubmed: 17638532
Bioorg Med Chem. 2015 Jul 1;23(13):3513-25
pubmed: 25935289
ACS Comb Sci. 2016 Feb 8;18(2):100-16
pubmed: 26812086
Mol Pharmacol. 2004 Oct;66(4):824-33
pubmed: 15231869
Bioorg Med Chem. 2008 Aug 1;16(15):7225-33
pubmed: 18620864
Future Med Chem. 2010 Oct;2(10):1529-46
pubmed: 21426147
Assay Drug Dev Technol. 2007 Dec;5(6):723-35
pubmed: 18181689
Pharmazie. 2021 Sep 1;76(9):412-415
pubmed: 34481530
J Enzyme Inhib Med Chem. 2016;31(sup2):180-188
pubmed: 27353698
J Chem Inf Model. 2017 Mar 27;57(3):417-427
pubmed: 28165734
ACS Chem Biol. 2012 Feb 17;7(2):367-77
pubmed: 22070201
PLoS One. 2017 Mar 14;12(3):e0173246
pubmed: 28291789
Biochem J. 2006 May 1;395(3):483-91
pubmed: 16441242
Chem Biol Drug Des. 2020 Oct;96(4):1024-1051
pubmed: 32394628
Alzheimers Dement (N Y). 2023 May 17;9(2):e12394
pubmed: 37215505
J Med Chem. 2010 Feb 11;53(3):1004-14
pubmed: 20041667
J Chem Inf Model. 2018 Sep 24;58(9):1847-1857
pubmed: 30105913
J Chem Biol. 2010 Mar;3(1):37-44
pubmed: 19779939
Nature. 2014 Sep 25;513(7519):481-3
pubmed: 25254460
J Biomol Screen. 2006 Aug;11(5):497-510
pubmed: 16760373
Eur J Med Chem. 2007 Aug;42(8):1102-8
pubmed: 17367895
Int J Mol Sci. 2022 Feb 25;23(5):
pubmed: 35269684
ChemMedChem. 2011 Aug 1;6(8):1411-22
pubmed: 21626699
J Biol Chem. 2023 Oct 20;:105382
pubmed: 37866628
J Biomol Screen. 2011 Sep;16(8):852-61
pubmed: 21788392
Bioorg Med Chem Lett. 2019 Aug 1;29(15):1948-1953
pubmed: 31133533
Bioorg Med Chem Lett. 2014 Feb 1;24(3):786-9
pubmed: 24418775
J Lipid Res. 2016 Mar;57(3):368-79
pubmed: 26768655
Mol Pharmacol. 2005 Nov;68(5):1301-10
pubmed: 16118363
J Med Chem. 2006 Jan 26;49(2):523-33
pubmed: 16420039